LifeVantage Corp  

(Public, NASDAQ:LFVN)   Watch this stock  
Find more results for LFVN
4.10
-0.16 (-3.76%)
Jul 21 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 4.00 - 4.28
52 week 3.70 - 14.98
Open 4.28
Vol / Avg. 0.00/132,004.00
Mkt cap 56.16M
P/E 16.16
Div/yield     -
EPS 0.25
Shares 14.23M
Beta 0.64
Inst. own 26%
May 10, 2017
Q3 2017 LifeVantage Corp Earnings Call - Webcast
May 10, 2017
Q3 2017 LifeVantage Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '17) 2016
Net profit margin 0.14% 2.91%
Operating margin 0.50% 6.49%
EBITD margin - 7.41%
Return on average assets 0.52% 13.37%
Return on average equity 1.72% 77.89%
Employees 208 -
CDP Score - -

Address

9785 S. Monroe Street, Suite 300
SANDY, UT 84070
United States - Map
+1-801-4329000 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

LifeVantage Corporation is a science-based network marketing company. The Company focuses on helping people achieve their health, wellness and financial independence goals. The Company provides products and a financially rewarding direct sales business opportunity to customers and independent distributors seeking a healthy lifestyle and financial freedom. It sells its products to preferred customers, retail customers and independent distributors located in the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand and the United Kingdom. The Company engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin care products, including Protandim, its scientifically-validated dietary supplement; LifeVantage TrueScience, its line of anti-aging skin care products; Canine Health; Axio, its energy drink mixes, and PhysIQ.

Officers and directors

Garry Paul Mauro Independent Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Darren Jay Jensen President, Chief Executive Officer, Director
Age: 47
Bio & Compensation  - Reuters
Steven R. Fife Chief Financial Officer
Age: 58
Bio & Compensation  - Reuters
Charles J. Wach Chief Operating Officer
Age: 54
Bio & Compensation  - Reuters
Michelle Oborn-Virchow Senior Vice President of Human Resources
Age: 36
Bio & Compensation  - Reuters
Ryan Goodwin Chief Marketing Officer
Age: 40
Bio & Compensation  - Reuters
Justin Rose Chief Sales Officer
Age: 48
Bio & Compensation  - Reuters
Raymond B. Greer Director
Age: 54
Bio & Compensation  - Reuters
Vinayak R. Hegde Director
Bio & Compensation  - Reuters
Darwin K. Lewis Director
Bio & Compensation  - Reuters